Upfront tofacitinib in patients with biological-naïve ulcerative colitis - An Indian multicentric experience.

Suprabhat GiriSukanya BhrugumallaAbhishek KamuniDebakanta MishraGirish Kumar PatiDhiraj AgrawalGovind VermaRohit WaghShamshersingh ChauhanMeghraj IngleSanjay ChandnaniShubham JainPravin M RathiAkash ShuklaAditya Kale

Published in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2023)

Upfront tofacitinib is effective in biologic-naïve Indian patients with moderate-severe UC. Further randomized studies are required to validate the study findings.

Keyphrases

ulcerative colitis
rheumatoid arthritis
open label
double blind
early onset
placebo controlled
high intensity
clinical trial
randomized controlled trial
phase ii
case control